Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   infection caused by helicobacter pylori
  

Disease ID 1819
Disease infection caused by helicobacter pylori
Definition

Helicobacter pylori (H. pylori) is a type of bacteria that causes infection in the stomach. It is found in about two-thirds of the world's population. It may be spread by unclean food and water, but researchers aren't sure. It causes Peptic ulcers and can also cause stomach cancer.

If you have symptoms of a peptic ulcer, your doctor will test your blood, breath or stool to see if it contains H. pylori. The best treatment is a combination of antibiotics and acid-reducing medicines. You will need to be tested after treatment to make sure the infection is gone.

To help prevent an H. pylori infection, you should

  • Wash your hands after using the bathroom and before eating
  • Eat properly prepared food
  • Drink water from a clean, safe source

NIH: National Institute of Diabetes and Digestive and Kidney Diseases


Synonym
h infection pylori
h infections pylori
h pylori infection
h. pylori infections
helicobacter infections pylori
helicobacter pylori infection
helicobacter pylori infections
infection caused by helicobacter pylori (disorder)
DOID
UMLS
C0850666
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:117)
C0017152  |  gastritis  |  43
C0024623  |  gastric cancer  |  31
C0030920  |  peptic ulcer  |  21
C0017154  |  atrophic gastritis  |  10
C0013295  |  duodenal ulcer  |  9
C0030920  |  peptic ulcers  |  7
C0242647  |  malt lymphoma  |  6
C0013295  |  duodenal ulcers  |  5
C0011847  |  diabetes  |  5
C0038358  |  gastric ulcer  |  5
C0038354  |  gastric disease  |  4
C0948265  |  metabolic syndrome  |  4
C0017168  |  esophageal reflux disease  |  4
C0001418  |  adenocarcinoma  |  4
C0002871  |  anemia  |  4
C0011849  |  diabetes mellitus  |  4
C0013289  |  duodenal diseases  |  4
C0038354  |  gastric diseases  |  4
C0017168  |  esophageal reflux  |  4
C0013289  |  duodenal disease  |  4
C0013395  |  dyspepsia  |  4
C0011860  |  type 2 diabetes  |  4
C0021831  |  bowel disease  |  3
C0038358  |  gastric ulcers  |  3
C0024299  |  lymphoma  |  3
C0030920  |  gastroduodenal ulcer  |  3
C0027051  |  myocardial infarction  |  3
C0017168  |  oesophageal reflux  |  3
C0027051  |  myocardial infarct  |  3
C0030920  |  peptic ulcer disease  |  3
C0278701  |  gastric adenocarcinoma  |  3
C0162316  |  iron deficiency anemia  |  3
C0242647  |  mucosa-associated lymphoid tissue  |  2
C0010068  |  coronary heart disease  |  2
C0023895  |  liver disease  |  2
C0017154  |  chronic atrophic gastritis  |  2
C0699791  |  gastric carcinoma  |  2
C0030920  |  peptic ulceration  |  2
C0024299  |  lymphomas  |  2
C0017168  |  gastro-oesophageal reflux disease  |  2
C0011860  |  type 2 diabetes mellitus  |  2
C0600260  |  obstructive pulmonary disease  |  2
C0023890  |  cirrhosis  |  2
C0017178  |  gastrointestinal disease  |  2
C0013295  |  duodenal ulcer disease  |  2
C0497327  |  dementia  |  2
C0024117  |  chronic obstructive pulmonary disease  |  2
C0024115  |  pulmonary disease  |  2
C0017168  |  gastro-oesophageal reflux  |  2
C0021831  |  intestinal disease  |  2
C0021831  |  intestinal diseases  |  2
C0030920  |  gastroduodenal ulcers  |  2
C0021390  |  inflammatory bowel disease  |  2
C0042373  |  vascular disease  |  2
C0017178  |  gastrointestinal diseases  |  2
C0040034  |  thrombocytopenia  |  1
C0034152  |  henoch-schonlein purpura  |  1
C0017168  |  gastro-esophageal reflux disease  |  1
C0011854  |  type 1 diabetes  |  1
C0026769  |  multiple sclerosis  |  1
C0155626  |  acute myocardial infarction  |  1
C0022661  |  end-stage renal disease  |  1
C1262481  |  eosinophilic gastroenteritis  |  1
C0017178  |  gastrointestinal disorder  |  1
C0038363  |  aphthous stomatitis  |  1
C0010068  |  coronary artery disease  |  1
C0677607  |  hashimoto's thyroiditis  |  1
C0338480  |  common migraine  |  1
C0017178  |  gastrointestinal disorders  |  1
C0152136  |  normal tension glaucoma  |  1
C0021053  |  immune disease  |  1
C0024623  |  gastric cancers  |  1
C0019158  |  hepatitis  |  1
C0042847  |  vitamin b12 deficiency  |  1
C0007222  |  cardiovascular disease  |  1
C0011881  |  diabetic nephropathy  |  1
C0235974  |  pancreatic cancer  |  1
C0030567  |  idiopathic parkinsonism  |  1
C0002871  |  anaemia  |  1
C0279628  |  esophageal adenocarcinoma  |  1
C0019196  |  hepatitis c  |  1
C0017168  |  gastro-esophageal reflux  |  1
C0162316  |  iron deficiency anaemia  |  1
C0014868  |  esophagitis  |  1
C0017160  |  gastroenteritis  |  1
C0032131  |  plasmacytoma  |  1
C0242647  |  mucosa-associated lymphoid tissue lymphoma  |  1
C0007137  |  squamous cell carcinoma  |  1
C0017168  |  gastroesophageal reflux disease  |  1
C0008325  |  cholecystitis  |  1
C0010674  |  cystic fibrosis  |  1
C0149931  |  migraine  |  1
C0162429  |  nutritional deficiency  |  1
C0042847  |  vitamin b12 defic  |  1
C0030925  |  perforated peptic ulcer  |  1
C0004153  |  atherosclerosis  |  1
C0021831  |  enteropathy  |  1
C0040053  |  thrombus  |  1
C0149931  |  migraine headache  |  1
C0007570  |  gluten-sensitive enteropathy  |  1
C0017168  |  gastroesophageal reflux  |  1
C1319315  |  colorectal adenocarcinoma  |  1
C0034150  |  purpura  |  1
C0038362  |  stomatitis  |  1
C0031090  |  periodontal disease  |  1
C0024623  |  stomach cancer  |  1
C0019151  |  hepatic encephalopathy  |  1
C0022658  |  renal disease  |  1
C0017612  |  open angle glaucoma  |  1
C0004096  |  asthma  |  1
C0149825  |  adenoid hypertrophy  |  1
C0017154  |  gastric atrophy  |  1
C0339573  |  primary open angle glaucoma  |  1
C0026636  |  oral disease  |  1
C0014869  |  reflux esophagitis  |  1
C0038354  |  gastric disorders  |  1
C0013295  |  duodenal ulceration  |  1
Curated Gene(Waiting for update.)
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:6)
1557  |  CYP2C19  |  infer
2524  |  FUT2  |  infer
2525  |  FUT3  |  infer
3117  |  HLA-DQA1  |  infer
3553  |  IL1B  |  infer
5225  |  PGC  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1819
Disease infection caused by helicobacter pylori
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:50)
HP:0005263  |  Gastritis  |  43
HP:0012126  |  Gastric cancer  |  32
HP:0004398  |  Peptic ulcer  |  21
HP:0005231  |  Chronic gastritis  |  11
HP:0002588  |  Duodenal ulcer  |  9
HP:0001903  |  Anemia  |  5
HP:0002592  |  Stomach ulcer  |  5
HP:0002020  |  Heartburn  |  4
HP:0000819  |  Diabetes mellitus  |  4
HP:0002665  |  Lymphoma  |  3
HP:0002027  |  Abdominal pain  |  3
HP:0001658  |  Myocardial infarction  |  3
HP:0001891  |  Iron-deficiency anemia  |  3
HP:0030731  |  Carcinoma  |  2
HP:0001394  |  Hepatic cirrhosis  |  2
HP:0001397  |  Hepatic steatosis  |  2
HP:0001873  |  Low platelet count  |  2
HP:0006510  |  Chronic obstructive pulmonary disease  |  2
HP:0002582  |  Chronic atrophic gastritis  |  2
HP:0001297  |  Cerebral vascular events  |  2
HP:0000726  |  Dementia  |  2
HP:0000979  |  Purpura  |  1
HP:0200123  |  Chronic liver inflammation  |  1
HP:0003774  |  End-stage renal failure  |  1
HP:0001082  |  Cholecystitis  |  1
HP:0002099  |  Asthma  |  1
HP:0002140  |  Ischemic stroke  |  1
HP:0001298  |  Encephalopathy  |  1
HP:0002242  |  Enteropathy  |  1
HP:0002960  |  Autoimmune condition  |  1
HP:0010280  |  Stomatitis  |  1
HP:0001410  |  Decreased liver function  |  1
HP:0011473  |  Villous atrophy  |  1
HP:0002480  |  Hepatic encephalopathy  |  1
HP:0002894  |  Neoplasia of the pancreas  |  1
HP:0012108  |  Primary open angle glaucoma  |  1
HP:0000872  |  Hashimoto's thyroiditis  |  1
HP:0002621  |  Atherosclerosis  |  1
HP:0002584  |  Intestinal hemorrhage  |  1
HP:0011857  |  Plasmacytoma  |  1
HP:0012594  |  High urine albumin levels  |  1
HP:0011107  |  Recurrent aphthous stomatitis  |  1
HP:0012115  |  Liver inflammation  |  1
HP:0001677  |  Coronary artery disease  |  1
HP:0012531  |  Pain  |  1
HP:0002076  |  Migraine headaches  |  1
HP:0100502  |  Vitamin B12 deficiency  |  1
HP:0100633  |  Inflammation of the esophagus  |  1
HP:0002860  |  Squamous cell carcinoma  |  1
HP:0002239  |  Gastrointestinal hemorrhage  |  1
Disease ID 1819
Disease infection caused by helicobacter pylori
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:31)
C0017152  |  gastritis  |  39
C0024623  |  gastric cancer  |  31
C0030920  |  peptic ulcer  |  13
C0017154  |  atrophic gastritis  |  10
C0013295  |  duodenal ulcer  |  9
C0085695  |  chronic gastritis  |  9
C0242647  |  malt lymphoma  |  6
C0030920  |  peptic ulcers  |  4
C0038354  |  gastric diseases  |  4
C0030920  |  ulcer disease  |  3
C0024299  |  lymphoma  |  3
C0162316  |  iron deficiency anemia  |  3
C0030920  |  gastroduodenal ulcer  |  3
C0017178  |  gastrointestinal diseases  |  2
C1283271  |  lymphocytic gastritis  |  2
C0013289  |  duodenal disease  |  2
C0242647  |  mucosa-associated lymphoid tissue  |  2
C0030920  |  peptic ulcer disease  |  2
C0017152  |  gastric inflammation  |  1
C1333782  |  malt lymphoma of the stomach  |  1
C0038358  |  gastric ulcers  |  1
C0017154  |  gastric atrophy  |  1
C0013289  |  duodenal diseases  |  1
C0876993  |  ventricular thrombus  |  1
C0032131  |  plasmacytoma  |  1
C0034150  |  purpura  |  1
C0162316  |  iron deficiency  |  1
C0031090  |  periodontal disease  |  1
C0349532  |  lymphoma of the stomach  |  1
C0267373  |  intestinal bleeding  |  1
C0010068  |  coronary artery disease  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:46)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1045642176972035243ABCB1umls:C0850666BeFreeEffect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.0.0069055992007ABCB1787509329AT,G
rs1045642186443895243ABCB1umls:C0850666BeFreeMDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.0.0069055992008ABCB1787509329AT,G
rs1045642220019875243ABCB1umls:C0850666BeFreeThe isolated C3435T ABCB1 SNP is not a major factor for genetic susceptibility to peptic ulcer, but in a group of men who suffered from peptic ulcer, this polymorphism seemed to be a risk factor for H. pylori infection development.0.0069055992011ABCB1787509329AT,G
rs10759932249291427099TLR4umls:C0850666BeFreeTLR4 rs10759932 decreased the risk of H. pylori infection (OR: 0.59, 95% CI: 0.41-0.86).0.0029858612014TLR49117702866TC
rs10983755250845127099TLR4umls:C0850666BeFreeEffect of the -2081G/A polymorphism of the TLR4 gene and its interaction with Helicobacter pylori infection on the risk of gastric cancer in Chinese individuals.0.0029858612015TLR49117702392GA
rs113641018716896142PARP1umls:C0850666BeFreePARP-1 762Ala/Ala could be a risk factor for gastric cancer in Han Chinese population; PARP-1 762Val/Ala polymorphism and Cag(+) H. pylori infection jointly contribute to higher risk for gastric cancer.0.0008143262009PARP11226367601AG
rs1143623216497245743PTGS2umls:C0850666BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0048859542011IL1B2112838252CG
rs1143623216497243553IL1Bumls:C0850666BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0274268992011IL1B2112838252CG
rs14870495626151690149233IL23Rumls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0002714422015IL17A652187772AG
rs1487049562615169050616IL22umls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0002714422015IL17A652187772AG
rs1487049562615169051561IL23Aumls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0005428842015IL17A652187772AG
rs148704956261516907040TGFB1umls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0008143262015IL17A652187772AG
rs148704956261516903605IL17Aumls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0010857672015IL17A652187772AG
rs1487049562615169059067IL21umls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0002714422015IL17A652187772AG
rs1487049562615169027189IL17Cumls:C0850666BeFreeWe evaluated the relationship between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with IL-6, IL-17, IL-21, IL-23 and TGF-β1 mRNAs expression in regard to H. pylori infection with chronic gastritis.0.0002714422015IL17A652187772AG
rs1800925216497243596IL13umls:C0850666BeFreeBorderline significant associations were seen between IL2-330G (rs2069762) (OR 1.45, 95% CI 0.95, 2.15, P = 0.06) and IL13-1111T (rs1800925) (OR 0.65, 95% CI 0.42, 1.01, P = 0.06) and H. pylori infection.0.0002714422011IL13;LOC1019277615132657117CT
rs1800925216497243558IL2umls:C0850666BeFreeBorderline significant associations were seen between IL2-330G (rs2069762) (OR 1.45, 95% CI 0.95, 2.15, P = 0.06) and IL13-1111T (rs1800925) (OR 0.65, 95% CI 0.42, 1.01, P = 0.06) and H. pylori infection.0.0010857672011IL13;LOC1019277615132657117CT
rs1801200216497243553IL1Bumls:C0850666BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0274268992011NANANANANA
rs1801200216497245743PTGS2umls:C0850666BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0048859542011NANANANANA
rs1801282205689695468PPARGumls:C0850666BeFreeAssociation between peroxisome proliferator-activated receptor-γ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis.0.0013572092010PPARG312351626CG
rs1801282183722845468PPARGumls:C0850666BeFreeThe study suggests that Pro12Ala PPARgamma polymorphism is associated with gastric adenocarcinoma and PUD, and is a potential marker for genetic susceptibility to these two diseases in the presence of H. pylori infection.0.0013572092008PPARG312351626CG
rs1801282258247605468PPARGumls:C0850666BeFreeNevertheless, prospectively designed cohort studies are needed to further investigate gene-gene and gene-environment interactions to confirm the combined effects of PPARγ Pro12Ala polymorphisms and H. pylori infection on gastric cancer risk.0.0013572092016PPARG312351626CG
rs1805192258247605468PPARGumls:C0850666BeFreeNevertheless, prospectively designed cohort studies are needed to further investigate gene-gene and gene-environment interactions to confirm the combined effects of PPARγ Pro12Ala polymorphisms and H. pylori infection on gastric cancer risk.0.0013572092016PPARG312379739CG
rs1805192205689695468PPARGumls:C0850666BeFreeAssociation between peroxisome proliferator-activated receptor-γ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis.0.0013572092010PPARG312379739CG
rs1805192183722845468PPARGumls:C0850666BeFreeThe study suggests that Pro12Ala PPARgamma polymorphism is associated with gastric adenocarcinoma and PUD, and is a potential marker for genetic susceptibility to these two diseases in the presence of H. pylori infection.0.0013572092008PPARG312379739CG
rs2069762216497243558IL2umls:C0850666BeFreeBorderline significant associations were seen between IL2-330G (rs2069762) (OR 1.45, 95% CI 0.95, 2.15, P = 0.06) and IL13-1111T (rs1800925) (OR 0.65, 95% CI 0.42, 1.01, P = 0.06) and H. pylori infection.0.0010857672011IL24122456825AC
rs2069762216497243596IL13umls:C0850666BeFreeBorderline significant associations were seen between IL2-330G (rs2069762) (OR 1.45, 95% CI 0.95, 2.15, P = 0.06) and IL13-1111T (rs1800925) (OR 0.65, 95% CI 0.42, 1.01, P = 0.06) and H. pylori infection.0.0002714422011IL24122456825AC
rs20758201988221210392NOD1umls:C0850666BeFreeThe significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?0.0013572092010NOD1730452621CT
rs2294008257217318000PSCAumls:C0850666BeFreeTwo recent genome-wide association studies in Asians have reported the association between the PSCA (prostate stem cell antigen) rs2294008C>T gene polymorphism and two Helicobacter pylori infection-related diseases such as gastric cancer (GC) and duodenal ulcer (DU).0.0008143262015PSCA8142680513CT
rs2297518205658004843NOS2umls:C0850666BeFreeThe aim of this study was to evaluate the association of NOS2 polymorphisms Ser608Leu (rs2297518) in exon 16, -954G/C and -1173C/T, both in the promoter region, with gastric cancer and chronic gastritis and the association of cancer with risk factors such as smoking, alcohol intake and H. pylori infection.0.0008143262010NOS21727769571GA
rs28362491226142384790NFKB1umls:C0850666BeFreeWe investigated the influence of NFKB1 polymorphisms, -94 ins/del (rs28362491) and -449 C>G (rs72696119), on the aberrant gene methylation under H. pylori infection.0.0008143262012NFKB1;LOC1053776214102500998ATTG-
rs3805246206024502549GAB1umls:C0850666BeFreeWe could not confirm a major association between Gab1 SNP (rs3805246) and the predisposition to H. pylori infection and CAG in this study population from Germany.0.0005428842010GAB14143382955GA
rs4646903236865651543CYP1A1umls:C0850666BeFreeWe studied the role of CYP2E1, CYP1A2 (rs762551), and CYP1A1 (rs4646903) polymorphisms in association with H. pylori infection in gastric carcinogenesis.0.0026384742013CYP1A11574719300AT,G
rs4833095256879127096TLR1umls:C0850666BeFreeA decreased risk of H. pylori infection was observed in subjects with TLR1 rs4833095 CT genotype [adjusted odds ratio (OR)=0.80; 95% confidence interval (CI): 0.66-0.96] or T allele (OR=0.82; 95%CI: 0.69-0.99).0.0005428842015TLR1438798089TC
rs4986790224680877099TLR4umls:C0850666BeFreeTo investigate toll-like receptor 2 (TLR2) -196 to -174 del, and TLR4 (+896A/G rs4986790 and +1196C/T rs4986791) polymorphisms at risk of chronic gastritis and gastric cancer in a Brazilian population and association of gastric lesions with risk factors such as smoking, alcohol intake and Helicobacter pylori infection.0.0029858612012TLR49117713024AG
rs4986790224680877097TLR2umls:C0850666BeFreeTo investigate toll-like receptor 2 (TLR2) -196 to -174 del, and TLR4 (+896A/G rs4986790 and +1196C/T rs4986791) polymorphisms at risk of chronic gastritis and gastric cancer in a Brazilian population and association of gastric lesions with risk factors such as smoking, alcohol intake and Helicobacter pylori infection.0.0016286512012TLR49117713024AG
rs4986791224680877097TLR2umls:C0850666BeFreeTo investigate toll-like receptor 2 (TLR2) -196 to -174 del, and TLR4 (+896A/G rs4986790 and +1196C/T rs4986791) polymorphisms at risk of chronic gastritis and gastric cancer in a Brazilian population and association of gastric lesions with risk factors such as smoking, alcohol intake and Helicobacter pylori infection.0.0016286512012TLR49117713324CT
rs4986791224680877099TLR4umls:C0850666BeFreeTo investigate toll-like receptor 2 (TLR2) -196 to -174 del, and TLR4 (+896A/G rs4986790 and +1196C/T rs4986791) polymorphisms at risk of chronic gastritis and gastric cancer in a Brazilian population and association of gastric lesions with risk factors such as smoking, alcohol intake and Helicobacter pylori infection.0.0029858612012TLR49117713324CT
rs5744174219944057097TLR2umls:C0850666BeFreeThese findings suggest that TLR2 c. -196 to -174 ins > del, TLR5 rs5744174 and interaction between rs5744174 and H. pylori infection were associated with the development of GC.0.0016286512011TLR51223111186AG
rs5744174219944057100TLR5umls:C0850666BeFreeThese findings suggest that TLR2 c. -196 to -174 ins > del, TLR5 rs5744174 and interaction between rs5744174 and H. pylori infection were associated with the development of GC.0.0005428842011TLR51223111186AG
rs667242019728008864RUNX3umls:C0850666BeFreeOur study results revealed that the RUNX3 intronic T/A polymorphism (rs760805) might modulate the risk of gastric atrophy among H. pylori seropositive subjects, and the RUNX3 T/A polymorphism at exon 1 (rs6672420) had little influence on the risks of H. pylori infection, gastric atrophy or gastric cancer in Japanese people.0.0029858612009RUNX3;LOC105376878124964519AT
rs689466216497243553IL1Bumls:C0850666BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0274268992011PTGS2;PACERR1186681619TC
rs689466216497245743PTGS2umls:C0850666BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0048859542011PTGS2;PACERR1186681619TC
rs72696119226142384790NFKB1umls:C0850666BeFreeWe investigated the influence of NFKB1 polymorphisms, -94 ins/del (rs28362491) and -449 C>G (rs72696119), on the aberrant gene methylation under H. pylori infection.0.0008143262012NFKB1;LOC1053776214102501347CG
rs76080519728008864RUNX3umls:C0850666BeFreeOur study results revealed that the RUNX3 intronic T/A polymorphism (rs760805) might modulate the risk of gastric atrophy among H. pylori seropositive subjects, and the RUNX3 T/A polymorphism at exon 1 (rs6672420) had little influence on the risks of H. pylori infection, gastric atrophy or gastric cancer in Japanese people.0.0029858612009RUNX3124925432AT
rs762551236865651543CYP1A1umls:C0850666BeFreeWe studied the role of CYP2E1, CYP1A2 (rs762551), and CYP1A1 (rs4646903) polymorphisms in association with H. pylori infection in gastric carcinogenesis.0.0026384742013CYP1A21574749576CA
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:62)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
1161484210rs368433TCrs368433236525232.00E-08NA1.37[1.23-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
1161485259rs17400517GTrs17400517236525234.95E-08NA1.37[1.23-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
1161492175rs9427401CGrs9427401236525234.57E-08NA1.37[1.23-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438710398rs11728133TCrs11728133236525231.10E-08NA1.23[1.15-1.33]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438711684rs13132956CTrs13132956236525232.69E-09NA1.3[1.19-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438724249rs1005938AGrs1005938236525232.69E-11NA1.3[1.19-1.39]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438724573rs7660102CArs7660102236525238.07E-11NA1.3[1.20-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438724593rs13135770GArs13135770236525239.58E-11NA1.3[1.20-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438724886rs12510962GArs12510962236525231.00E-10NA1.3[1.20-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438724945rs13137984CArs13137984236525236.98E-09NANANA2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438724945rs13137984CArs13137984236525237.00E-09NA1.22[1.14-1.30]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438726766rs4832786CGrs4832786236525233.93E-09NA1.22[1.14-1.30]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438728076rs7658334AGrs7658334236525232.70E-09NA1.22[1.15-1.32]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438728104rs7663292TCrs7663292236525232.88E-09NA1.22[1.15-1.32]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438732962rs10026553AGrs10026553236525238.19E-12NA1.28[1.19-1.37]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438736550rs2890620TCrs2890620236525234.65E-11NA1.27[1.19-1.37]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438744489rs4072590ATrs4072590236525235.12E-11NA1.27[1.18-1.37]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438750185rs9761637AGrs9761637236525235.46E-12NA1.28[1.19-1.37]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438751694rs4540058GArs4540058236525231.35E-11NA1.28[1.19-1.39]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438764112rs10024216GArs10024216236525234.01E-08NA1.2[1.12-1.28]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438765720rs10008492CTrs10008492236525232.06E-08NA1.2[1.14-1.30]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438774785rs10776482AGrs10776482236525231.57E-10NA1.3[1.20-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438774889rs4129009TA,C,Grs4129009236525233.17E-12NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438775040rs10776483AGrs10776483236525231.46E-10NA1.3[1.20-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438776180rs11096956CArs11096956236525231.56E-10NA1.3[1.20-1.41]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438777471rs4274855CTrs4274855236525233.05E-12NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438778203rs11466645ATrs11466645236525233.05E-12NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438778903rs11466640GArs11466640236525232.54E-12NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438780471rs11466617TCrs11466617236525233.05E-12NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438782221rs7653908GCrs7653908236525233.60E-15NA1.39[1.28-1.52]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438782420rs7658893GArs7658893236525239.86E-14NA1.35[1.25-1.45]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438783848rs11725309TCrs11725309236525232.35E-13NA1.39[1.27-1.52]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438784724rs10004195TArs10004195236525231.00E-18NA1.43[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438784724rs113143765TTArs10004195236525231.00E-18NA1.43[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438787216rs12233670CTrs12233670236525232.89E-18NA1.43[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438792524rs4543123AGrs4543123236525231.75E-18NA1.43[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438799710rs4833095TCrs4833095236525231.43E-18NA1.43[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438801285rs5743604AGrs5743604236525232.22E-18NA1.43[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438802528rs5743596GArs5743596236525232.43E-11NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438802644rs5743595AGrs5743595236525237.69E-13NA1.37[1.27-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438803063rs5743592AGrs5743592236525231.59E-13NA1.39[1.28-1.52]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438805489rs5743571CTrs5743571236525236.07E-13NA1.37[1.27-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438805983rs5743565TCrs5743565236525235.51E-13NA1.37[1.27-1.52]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438806019rs5743563AGrs5743563236525235.13E-13NA1.37[1.27-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438806096rs5743562TCrs5743562236525237.27E-12NA1.37[1.25-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438806827rs5743557GArs5743557236525234.30E-13NA1.39[1.27-1.52]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438810769rs11722813CTrs11722813236525231.44E-08NA1.56[1.33-1.82]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438811551rs2101521GArs2101521236525231.08E-15NA1.41[1.30-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438812876rs17616434TCrs17616434236525236.51E-18NA1.41[1.32-1.54]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438815502rs4833103ACrs4833103236525231.09E-10NA1.23[1.16-1.32]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438816338rs6815814ACrs6815814236525236.95E-18NA1.41[1.30-1.52]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438832727rs5743794CTrs5743794236525233.63E-12NA1.35[1.23-1.47]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438845198rs7673348GArs7673348236525236.49E-13NA1.35[1.23-1.45]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438846979rs7687447CGrs7687447236525235.08E-13NA1.35[1.23-1.47]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438859339rs2174284CTrs2174284236525239.44E-12NA1.35[1.23-1.47]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438862121rs3860069ACrs3860069236525231.02E-12NA1.35[1.25-1.47]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438867427rs17582830AGrs17582830236525233.37E-11NA1.33[1.22-1.45]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438886420rs17582893GArs17582893236525235.01E-11NA1.33[1.22-1.45]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438891173rs1873195CTrs1873195236525232.35E-11NA1.33[1.22-1.45]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438892649rs17582921TCrs17582921236525232.39E-11NA1.33[1.22-1.45]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438893843rs6851685GTrs6851685236525233.80E-15NA1.37[1.27-1.47]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
438894380rs6835514AGrs6835514236525231.08E-15NA1.37[1.27-1.49]2,623 European ancestry high titer cases; 7,862 European ancestry low or no titer controlsEuropean(10485)ALL(10485)EUR(10485)ALL(10485)Helicobacter pylori serologic statusHPOID:0005202Helicobacter pylori infectionDOID:3686DOID:4036DOID:5663DOID:7979Helicobacter pylori infectious diseaseHelicobacter pylori gastritishelicobacter pylori-related carcinomahelicobacter pylori-related gastric adenocarcinomaNANAEFOID:0005247
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)